Arima Genomics Announces Distribution Partnership with Active Motif for Research-Specific Hi-C Sequencing Kits and Services

CARLSBAD, Calif.--(BUSINESS WIRE)--Arima Genomics, Inc., a cancer diagnostics company bringing DNA sequence and structure together to advance cancer therapy selection, today announced a distribution partnership with Active Motif Incorporated, a leading provider of epigenetics and multiomic solutions to mechanistic, translational, and clinical researchers, under which Active Motif will be granted exclusive distribution rights to Arima’s Hi-C kits and services for research applications. Under the